文献速递中医妇科中药与中成药合理使用

重楼总皂苷经肠道奇异变形杆菌2024调控雌激素代谢改善异常子宫出血

Paridis rhizoma total saponins ameliorate abnormal uterine bleeding via regulating Proteus mirabilis 2024-mediated estrogen metabolism in the gut-reproductive axis.
PubMed 文献 · Phytomedicine · 2026-07-09

本研究在大鼠早期妊娠不全流产所致异常子宫出血(AUB)模型中评价重楼总皂苷(PRS)的疗效,并结合多组学与菌株分离验证机制。PRS剂量依赖性减轻子宫卵巢损伤并恢复雌激素稳态,鉴定多叶重楼皂苷I与巴黎皂苷VII为核心活性单体,首次揭示PM_2024菌株及PM_2024_3180基因介导E2向E1转化是PRS抗AUB的肠道-生殖轴机制。

要点

  • PRS剂量依赖性改善AUB大鼠子宫卵巢病理并恢复雌激素稳态。
  • 多叶重楼皂苷I与巴黎皂苷VII为PRS抗AUB核心活性单体。
  • PM_2024菌株及其PM_2024_3180基因介导E2向E1转化是关键机制环节。

核心结论

  • PRS通过富集肠道PM_2024菌株、增强其E2代谢能力并上调卵巢HSD17B2/HSD17B8表达,经肠道-生殖轴发挥抗AUB作用。

研究设计与样本

  • 采用大鼠早期妊娠不全流产诱导的AUB模型评价PRS疗效。
  • 以UHPLC-MS/MS表征PRS化学轮廓与体内分布,并整合子宫转录组、粪便多组学、粪菌移植、细菌分离、基因功能验证及单体化合物给药解析机制。

主要发现

  • PRS剂量依赖性减轻AUB大鼠子宫与卵巢病理损伤,缓解子宫炎症与卵巢凋亡。
  • PRS使AUB大鼠血清雌二醇(E2)显著降低、雌酮(E1)升高,恢复全身雌激素稳态。
  • 多叶重楼皂苷I(PI)与巴黎皂苷VII(PVII)被鉴定为PRS核心活性单体。
  • 首次分离鉴定PM_2024为驱动E2向E1转化的关键菌株,PM_2024_3180基因编码短链脱氢酶/还原酶(SDR)为雌激素代谢核心功能元件。
  • PRS及PI/PVII显著富集肠道PM_2024、增强其E2代谢能力、上调卵巢HSD17B2/HSD17B8并调控子宫雌激素信号通路中FKBP5/PGR。

临床怎么用

  • 为宫血宁胶囊类重楼总皂苷制剂抗AUB提供以肠道菌群为靶点的微生态治疗思路。
  • PI与PVII可作为PRS质量控制与活性评价的潜在核心单体指标。
  • PM_2024菌株及PM_2024_3180基因可作为AUB等激素相关妇科疾病微生态干预的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Abnormal uterine bleeding (AUB) is a highly prevalent gynecological disorder worldwide, for which first-line steroid hormone therapy is limited by well-documented adverse effects. Paridis rhizoma total saponins (PRS) are the core pharmacodynamic material basis of Gongxuening Capsules, a classic traditional Chinese medicine (TCM) formula with well-validated clinical hemostatic efficacy for AUB. However, its active ingredients and underlying therapeutic mechanisms remain largely unclear, especially the potential regulatory role of the gut-reproductive axis. This study aimed to systematically elucidate the anti-AUB mechanism of PRS. METHODS: The therapeutic effect of PRS was evaluated in a rat model of AUB induced by incomplete abortion in early pregnancy. Ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was used to characterize the chemical profile and in vivo distribution of PRS. Integrative analysis of uterine transcriptomics, fecal multi-omics, fecal microbiota transplantation, bacterial isolation, gene functional validation, and administration of individual monomeric compound was performed to decipher the mechanism. RESULTS: PRS dose-dependently alleviated uterine and ovarian pathological damage, mitigated uterine inflammation and ovarian apoptosis, and restored systemic estrogen homeostasis in AUB rats, characterized by significantly reduced serum estradiol (E2) and elevated estrone (E1). Polyphyllin I (PI) and Paris saponin VII (PVII) were identified as the core active monomers of PRS. We first isolated and identified Proteus mirabilis 2024 (PM_2024) as the key bacterial strain driving the conversion of E2 to E1, and confirmed that the PM_2024_3180 gene was the core functional element encoding short-chain dehydrogenase/reductase (SDR) for estrogen metabolism. Mechanistically, PRS and its active monomers PI/PVII significantly enriched intestinal PM_2024, enhanced its E2 metabolic capacity, upregulated ovarian HSD17B2/HSD17B8 expression, and modulated FKBP5/PGR within the uterine estrogen signaling pathway to exert anti-AUB effects. CONCLUSION: This study elucidates a novel estrogen-mediated gut-reproductive axis mechanism of PRS against AUB for the first time, deciphers the scientific connotation of the classic hemostatic TCM Paridis rhizoma, and provides a novel gut microbiota-targeted microecological therapeutic strategy for AUB and other hormone-related gynecological disorders.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Ren H, Zhao C, Fan Q, et al. Paridis rhizoma total saponins ameliorate abnormal uterine bleeding via regulating Proteus mirabilis 2024-mediated estrogen metabolism in the gut-reproductive axis. Phytomedicine. 2026. PMID: 42462533. doi:10.1016/j.phymed.2026.158561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。